The potent preclinical activity of CCT137690 suggests that this inhibitor may benefit patients with MYCN amplified neuroblastoma
p21 mRNA levels are found to increase concomitantly with levels of NVP-CGM097 in tumor-bearing rats dosed at 30 mg/kg
InChi: InChI=1S/C32H42Cl2N4O3/c1-35(2)30(40)31(38-16-7-4-8-17-38)13-18-36(19-14-31)20-15-32(26-11-12-27(33)28(34)23-26)24-37(21-22-41-32)29(39)25-9-5-3-6-10-25/h3
3-dihydro-1-benzofuran-4-yl)methyl]-1-methanesulfonylimidazo[1
1, 2, 3, 4-Tetramethylbenzene - CAS# 488-23-3 Catalog No.:M31011-C The potent preclinical activity of1,2,3,4 Tetramethylbenzene consists of a benzene ring with four methyl groups ( CH3) as a substituent. 1,2,3,4 Tetramethylbenzene is a specialty product for biochemistry research. Product information CAS Number: 488 23 3 Molecular Weight: 134. 22 Formula: C10H14 Chemical Name: 1,2,3,4 tetramethylbenzene Smiles: CC1=CC=C(C)C(C)=C1C InChiKey: UOHMMEJUHBCKEE UHFFFAOYSA N InChi: InChI=1S C10H14 c1 7 5 6 8(2)10(4)9(7)3 h5 6H,1 4H3 Technical Data